By staying abreast of signs and risk factors, such as persistent indigestion, unexplained weight loss, or discomfort in the ...

Clear cell carcinoma (CCC) is a rare and aggressive form of cancer that can arise from endometriosis, particularly in the abdominal wall. Endometriosis is a condition where tissue similar to the ...

Tevimbra, or tislelizumab-jsgr, is approved as a first-line treatment for adults suffering from a certain type of unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

Recognising the pressing need for new therapies, the FDA has already granted a fast-track designation to zolbetuximab for the treatment of gastric and GEJ adenocarcinoma. Other companies ...

To distinguish ovarian carcinoma from these other, less threatening conditions, an effective screening strategy is needed. Rao GJ, Ravi BS, Cheriparambil KM, Pachter B, Pujol F. Abdominal ...

Approval of Tevimbra was supported by the RATIONALE-305 Phase III trial, which demonstrated a significant overall survival benefit in patients with unresectable or metastatic HER2-negative gastric or ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...

Rao GJ, Ravi BS, Cheriparambil KM, Pachter B, Pujol F. Abdominal Tuberculosis or Ovarian Carcinoma: Management Dilemma Associated With an Elevated CA-125 Level. MedGenMed 1(1) 1999. [formerly ...